Your session is about to expire
← Back to Search
Behavioral Intervention
SkillTalk for HIV/AIDS Prevention
N/A
Recruiting
Research Sponsored by Philliber Research & Evaluation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 week
Awards & highlights
Study Summary
This trial evaluates SkillTalk, an online video library, for its ability to improve the sexual health education skills of high school educators.
Eligible Conditions
- HIV/AIDS Prevention
- Sexually Transmitted Infections Prevention
- Birth Control
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 week
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Demonstrable use of microskills
Secondary outcome measures
Knowledge of microskills
Self-efficacy and comfort
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: SkillTalkExperimental Treatment1 Intervention
Participants will receive one week of access to SkillTalk, a subscription-based microskills video training library designed to enhance the skills of high school sex educators to implement the frequently used core components of sexual and reproductive health (SRH) curricula.
Group II: Business as usualActive Control1 Intervention
Control group will receive "business as usual."
Find a Location
Who is running the clinical trial?
Philliber Research & EvaluationLead Sponsor
7 Previous Clinical Trials
17,078 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You feel comfortable taking part in the study and fulfilling your role.
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there still slots available for patients to join this clinical trial?
"Indeed, according to the details on clinicaltrials.gov this trial is searching for participants. It was first announced on August 9th 2022 and has been recently renewed as of July 14th 2023."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger